Business Wire
16 Jul 2026, 12:32 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Niagen Bioscience appointed Abhijit Kale, Ph.D., as Senior Director of Global External Research. — Personnel appointments are generally low-impact unless they involve the CEO or CFO, though this signals a commitment to expanding clinical research collaborations.
+0.10Which stocks this story touches
The company announced the strategic appointment of a new Senior Director for its global research program.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
2h ago
